Brilacidin First-in-Class Defensin-Mimetic Drug C
Post# of 72440
First-in-Class Defensin-Mimetic Drug Candidate
Mechanism of Action, Pre/Clinical Data and Academic Literature Supporting the Development of Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment
April 20, 2020
https://static1.squarespace.com/static/571535....20.20.pdf